Legal & General Investment Management

Legal & General Investment Management (LGIM) is a preeminent global asset management firm and the investment subsidiary of the Legal & General Group. As one of Europe's largest investors, LGIM manages a diverse range of assets for institutional and retail clients, including significant holdings in the global pharmaceutical and biotechnology industries. The firm is particularly active in the healthcare sector through its thematic investment strategies, such as the Healthcare Breakthrough UCITS ETF, which targets innovation in areas like gene editing and robotic surgery. LGIM is a global leader in ESG integration, frequently engaging with healthcare companies on issues of drug pricing, access to medicine, and corporate governance. Headquartered in London, the firm maintains a robust international presence across the United States, Asia, and Europe.